MedTrace Logo

Heart and Lung Function Monitoring System

NCT02168049 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-03-06

No results posted yet for this study

Summary

The investigator goal is to test a new device to see if it can provide continuous and simultaneous monitoring of heart and lung function.

Conditions

  • Heart Diseases
  • Lung Diseases

Interventions

DEVICE

Integrated CardioRespiratory System

Participants will be asked to wear a non-invasive band on their upper abdomen while laying down. This band includes acoustic sensors. A remote monitoring device will continuously monitor and record heart rate and lung volumes and function.

DEVICE

Transthoracic Echocardiography (TTE)

Participants will undergo a TTE examination. During the TTE, a technician obtains views of the heart by moving a small instrument called a transducer to different locations on the chest or abdominal wall.

DEVICE

Electrocardiography

Participants will also have ECG monitoring as part of the TTE exam, which records the electrical activity of the heart using electrodes placed on the body.

Sponsors & Collaborators

Principal Investigators

  • Kimberly Howard-Quijano, M.D., M.S. · University of California, Los Angeles

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02168049 on ClinicalTrials.gov